CRISPR Therapeutics AG (CRSP) EBITDA Margin Growth (1y) (2017 - 2026)

CRISPR Therapeutics AG (CRSP) EBITDA Margin Growth (1y) (2017 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA Margin Growth (1y) (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-143.00
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	78.00
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	1,049.00
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	1,238.00
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-7.76 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-1,651.00
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	2,002.00
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	29,091.00
10	CRISPR Therapeutics AG	5.18 Bn	5.18 Bn	-	2.46 Mn

Download Data